China fines Johnson & Johnson in landmark price-fixing case

August 2, 2013 by Brad Perriello

The Chinese government fines Johnson & Johnson for setting a price floor and firing a Chinese distributor, Rainbow Medical, for breaking it.

China fines Johnson & Johnson in landmark price-fixing case

Johnson & Johnson (NYSE:JNJ) won the dubious distinction of being the 1st Fortune 500 company to be fined for price fixing in China, according to a newspaper there.

The healthcare giant was fined 530,000 yuan (about $86,456) by the Shanghai High People's Court yesterday to compensate a former Chinese distributor, Rainbow Medical, China Daily reported.

The court found that J&J set a price floor for products sold by Rainbow in their contract, later penalizing the company and finally failing to renew the contract, according to the newspaper.

Sign up to get our free newsletters delivered right to your inbox.

"The practice of placing a minimum resale price made Johnson & Johnson avoid price competition and confined the market competition of similar products, which kept the price of the equipment at a high level and damaged consumer interests," chief judge Ding Wenlian said, according to the report. "The market for medical instruments in China faced a lack of competition."

It's the 1st vertical monopoly lawsuit and the 1st ruling in favor of the plaintiff in an antitrust case in China, according to the newspaper.

Comments